Literature DB >> 29122885

C/EBPα transcription factor is regulated by the RANK cytoplasmic 535IVVY538 motif and stimulates osteoclastogenesis more strongly than c-Fos.

Joel Jules1, Wei Chen2, Xu Feng1, Yi-Ping Li3.   

Abstract

Binding of receptor activator of NF-κB ligand (RANKL) to its receptor RANK on osteoclast (OC) precursors up-regulates c-Fos and CCAAT/enhancer-binding protein-α (C/EBPα), two critical OC transcription factors. However, the effects of c-Fos and C/EBPα on osteoclastogenesis have not been compared. Herein, we demonstrate that overexpression of c-Fos or C/EBPα in OC precursors up-regulates OC genes and initiates osteoclastogenesis independently of RANKL. However, although C/EBPα up-regulated c-Fos, c-Fos failed to up-regulate C/EBPα in OC precursors. Consistently, C/EBPα overexpression more strongly promoted OC differentiation than did c-Fos overexpression. RANK has a cytoplasmic 535IVVY538 (IVVY) motif that is essential for osteoclastogenesis, and we found that mutation of the IVVY motif blocked OC differentiation by partly inhibiting expression of C/EBPα but not expression of c-Fos. We therefore hypothesized that C/EBPα overexpression might rescue osteoclastogenesis in cells expressing the mutated IVVY motif. However, overexpression of C/EBPα or c-Fos failed to stimulate osteoclastogenesis in the mutant cells. Notably, the IVVY motif mutation abrogated OC gene expression compared with a vector control, suggesting that the IVVY motif might counteract OC inhibitors during osteoclastogenesis. Consistently, the IVVY motif mutant triggered up-regulation of recombinant recognition sequence-binding protein at the Jκ site (RBP-J) protein, a potent OC inhibitor. Mechanistically, C/EBPα or c-Fos overexpression in the mutant cells failed to control the up-regulated RBP-J expression, leading to suppression of OC genes. Accordingly, RBP-J silencing in the mutant cells rescued osteoclastogenesis with C/EBPα or c-Fos overexpression with C/EBPα exhibiting a stronger osteoclastogenic effect. Collectively, our findings indicate that C/EBPα is a stronger inducer of OC differentiation than c-Fos, partly via C/EBPα regulation by the RANK 535IVVY538 motif.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  CCAAT/enhancer-binding protein (C/EBP); NFAT transcription factor; bone; c-Fos; differentiation; osteoclast; transcription factor

Mesh:

Substances:

Year:  2017        PMID: 29122885      PMCID: PMC5787821          DOI: 10.1074/jbc.M116.736009

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.

Authors:  Hiroshi Takayanagi; Sunhwa Kim; Takako Koga; Hiroshi Nishina; Masashi Isshiki; Hiroki Yoshida; Akio Saiura; Miho Isobe; Taeko Yokochi; Jun-ichiro Inoue; Erwin F Wagner; Tak W Mak; Tatsuhiko Kodama; Tadatsugu Taniguchi
Journal:  Dev Cell       Date:  2002-12       Impact factor: 12.270

2.  Inhibition of Rgs10 Expression Prevents Immune Cell Infiltration in Bacteria-induced Inflammatory Lesions and Osteoclast-mediated Bone Destruction.

Authors:  Sen Yang; Liang Hao; Matthew McConnell; Xuedong Zhou; Min Wang; Yan Zhang; John D Mountz; Michael Reddy; Paul D Eleazer; Yi-Ping Li; Wei Chen
Journal:  Bone Res       Date:  2013-09-01       Impact factor: 13.567

3.  IL-1 mediates TNF-induced osteoclastogenesis.

Authors:  Shi Wei; Hideki Kitaura; Ping Zhou; F Patrick Ross; Steven L Teitelbaum
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

Review 4.  Disorders of bone remodeling.

Authors:  Xu Feng; Jay M McDonald
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

Review 5.  Bone resorption by osteoclasts.

Authors:  S L Teitelbaum
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

6.  Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos.

Authors:  Koichi Matsuo; Deborah L Galson; Chen Zhao; Lan Peng; Catherine Laplace; Kent Z Q Wang; Marcus A Bachler; Hitoshi Amano; Hiroyuki Aburatani; Hiromichi Ishikawa; Erwin F Wagner
Journal:  J Biol Chem       Date:  2004-04-08       Impact factor: 5.157

Review 7.  The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control.

Authors:  Claus Nerlov
Journal:  Trends Cell Biol       Date:  2007-07-19       Impact factor: 20.808

8.  Core binding factor beta (Cbfβ) controls the balance of chondrocyte proliferation and differentiation by upregulating Indian hedgehog (Ihh) expression and inhibiting parathyroid hormone-related protein receptor (PPR) expression in postnatal cartilage and bone formation.

Authors:  Fei Tian; Mengrui Wu; Yi-Ping Li; Wei Chen; Lianfu Deng; Guochun Zhu; Junqing Ma; Bo Gao; Lin Wang
Journal:  J Bone Miner Res       Date:  2014-07       Impact factor: 6.741

9.  RBP-J imposes a requirement for ITAM-mediated costimulation of osteoclastogenesis.

Authors:  Susan Li; Christine H Miller; Eugenia Giannopoulou; Xiaoyu Hu; Lionel B Ivashkiv; Baohong Zhao
Journal:  J Clin Invest       Date:  2014-10-20       Impact factor: 19.456

10.  RANK receptor oligomerisation in the regulation of NFκB signalling.

Authors:  S Das; I Sepahi; A Duthie; S Clark; J C Crockett
Journal:  J Mol Endocrinol       Date:  2014-05-23       Impact factor: 5.098

View more
  6 in total

1.  Compliant substratum modulates vinculin expression in focal adhesion plaques in skeletal cells.

Authors:  Chenchen Zhou; Qingxuan Wang; Demao Zhang; Linyi Cai; Wei Du; Jing Xie
Journal:  Int J Oral Sci       Date:  2019-06-01       Impact factor: 6.344

2.  Knockout and Double Knockout of Cathepsin K and Mmp9 reveals a novel function of Cathepsin K as a regulator of osteoclast gene expression and bone homeostasis.

Authors:  Guochun Zhu; Wei Chen; Chen-Yi Tang; Abigail McVicar; Diep Edwards; Jinwen Wang; Matthew McConnell; Shuying Yang; Yang Li; Zhijie Chang; Yi-Ping Li
Journal:  Int J Biol Sci       Date:  2022-08-29       Impact factor: 10.750

Review 3.  Role of Biomolecules in Osteoclasts and Their Therapeutic Potential for Osteoporosis.

Authors:  Xin Zhao; Suryaji Patil; Fang Xu; Xiao Lin; Airong Qian
Journal:  Biomolecules       Date:  2021-05-17

4.  The loss of STAT3 in mature osteoclasts has detrimental effects on bone structure.

Authors:  Rebecca K Davidson; Evan R Himes; Shinya Takigawa; Andy Chen; M Ryne Horn; Tomas Meijome; Joseph M Wallace; Melissa A Kacena; Hiroki Yokota; Andrew V Nguyen; Jiliang Li
Journal:  PLoS One       Date:  2020-07-30       Impact factor: 3.240

5.  F2r negatively regulates osteoclastogenesis through inhibiting the Akt and NFκB signaling pathways.

Authors:  Yan Zhang; He Wang; Guochun Zhu; Airong Qian; Wei Chen
Journal:  Int J Biol Sci       Date:  2020-03-12       Impact factor: 6.580

Review 6.  At the Crossroads of the Adipocyte and Osteoclast Differentiation Programs: Future Therapeutic Perspectives.

Authors:  Shanmugam Muruganandan; Andreia M Ionescu; Christopher J Sinal
Journal:  Int J Mol Sci       Date:  2020-03-26       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.